Biogen Inc. (BIIB) vs Medline Inc. (MDLN)
BIIB leads on 9 of 11 compared metrics.
A side-by-side comparison of Biogen Inc. and Medline Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BIIB vs MDLN
growth of $100 · last 1yBIIB +16.2%MDLN -10.7%BIIB compounded faster
BIIB MDLN
BIIB vs MDLN: by the numbers
- •MDLN is the larger company ($30.96B vs $29.53B market cap).
- •BIIB trades at the lower earnings multiple (21.42 vs 30.26 P/E).
- •BIIB converts more revenue to profit (13.92% vs 3.31% net margin).
Which is better, BIIB or MDLN?
Metric tally: BIIB 9 · MDLN 2It depends on what you're optimizing for:
ValueBIIB(lower P/E)
QualityBIIB(higher ROIC)
Valuation
| Metric | BIIB | MDLN |
|---|---|---|
| P/E ratio | 21.42● | 30.26 |
| Forward P/E | 12.23● | 22.08 |
| P/S ratio | 3.01 | 1.04● |
| P/B ratio | 1.59● | 2.68 |
| EV / EBITDA | 12.16● | 14.84 |
| FCF yield | 8.83%● | 5.05% |
Profitability
| Metric | BIIB | MDLN |
|---|---|---|
| Gross margin | 69.77%● | 24.04% |
| Operating margin | 15.65%● | 7.04% |
| Net margin | 13.92%● | 3.31% |
| ROE | 7.36% | 8.55%● |
| ROIC | 6.62%● | 5.69% |
Growth (annualized)
| Metric | BIIB | MDLN |
|---|---|---|
| Revenue CAGR (5Y) | -4.80% | — |
| EPS CAGR (5Y) | -18.67% | — |
| FCF CAGR (5Y) | -3.59% | — |
| Total return CAGR (5Y) | -12.79% | — |
Frequently asked
- Which is better, BIIB or MDLN?
- It depends on your goal. value: BIIB (lower P/E); quality: BIIB (higher ROIC). Across all compared metrics, BIIB leads 9 to 2.
- Is BIIB or MDLN cheaper?
- On trailing earnings, BIIB is cheaper: BIIB trades at a 21.42 P/E and MDLN at 30.26.
- Is BIIB or MDLN more profitable?
- BIIB runs the higher net margin — BIIB at 13.92% versus MDLN at 3.31%.
Go deeper
Dig into the metrics
Biogen P/E ratioMedline P/E ratioBiogen dividend yieldMedline dividend yieldBiogen ROEMedline ROEBiogen operating marginMedline operating marginBiogen revenue growthMedline revenue growthBiogen free cash flowMedline free cash flow
Biogen & Medline appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.